Dr. Jeff Moses Illustrates Typical High-Risk Patient at CHIP Course
Nearly 100 interventional and clinical cardiologists from around the country gathered in Fort Lauderdale to collaborate and watch presentations and case reviews from leading physicians in the industry. The course, “CHIP: Hemodynamic Support and Complex PCI” taking place on January 23-24, 2016, was hosted by the Cardiovascular Research Foundation and was organized by leading interventional cardiologists in the field: Drs. Ajay Kirtane, Marty Leon, and Jeffrey Moses from New York Presbyterian Hospital/Columbia University Medical Center, and Dr. John Lasala from Washington University School of Medicine.
Dr. Jeff Moses illustrated a typical “CHIP” (Complex Higher risk and Indicated Patients) patient by presenting a case review of a patient with existing ischemic cardiomyopathy who was told there were no options and referred for stem cell therapy. Diagnostic angiography revealed multi-vessel coronary artery disease, and Dr. Moses performed multi-vessel PCI with hemodynamic support using the Impella® heart pump. The outcome was successful.
- Learn more about the hemodynamics of Protected PCI with the Impella 2.5 heart pump
- Learn more about the clinical data associated with Protected PCI
To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: abiomed.com/important-safety-information